or Try an Advanced Search...

    Technical Analysis for BTCY - Biotricity, Inc.

    Grade Last Price % Change Price Change
    C 0.32 -19.63% -0.08
    BTCY closed up 8.11 percent on Thursday, November 14, 2024, on approximately normal volume. It was able to find support at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BTCY trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish -19.63%
    50 DMA Support Bullish -19.63%
    MACD Bullish Centerline Cross Bullish -19.63%
    Doji - Bearish? Reversal -19.63%
    Wide Bands Range Expansion -19.63%
    Gapped Up Strength -19.63%
    Up 3 Days in a Row Strength -19.63%
    Crossed Above 20 DMA Bullish -13.11%
    Crossed Above 50 DMA Bullish -13.11%
    Earnings Movers Other -13.11%
    Older End-of-Day Signals for BTCY ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 1 day ago
    Down 3% 1 day ago
    Fell Below 50 DMA 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BTCY Chart by TradingView
    Basic chart:

    Profile

    Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic products for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Health Care Chronic Condition Connected Health Healthcare Market Chronic Care Management

    Is BTCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th
    Oct 4 Biotricity reaches EBITDA positive on go-forward cash basis
    Oct 3 Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
    Sep 19 Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals
    Aug 21 Biotricity reports Q1 results
    Aug 21 Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025
    Jul 26 LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Jul 22 Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
    Jul 19 Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Jul 17 SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
    See more BTCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.03
    52 Week Low 0.186
    Average Volume 64,606
    200-Day Moving Average 0.87
    50-Day Moving Average 0.34
    20-Day Moving Average 0.33
    10-Day Moving Average 0.36
    Average True Range 0.08
    RSI (14) 56.52
    ADX 17.0
    +DI 24.05
    -DI 20.63
    Chandelier Exit (Long, 3 ATRs) 0.26
    Chandelier Exit (Short, 3 ATRs) 0.43
    Upper Bollinger Bands 0.46
    Lower Bollinger Band 0.19
    Percent B (%b) 0.77
    BandWidth 83.84
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram 0.0083
    Fundamentals Value
    Market Cap 3.51 Million
    Num Shares 8.77 Million
    EPS -1.96
    Price-to-Earnings (P/E) Ratio -0.20
    Price-to-Sales 0.66
    Price-to-Book 33.02
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.59
    Resistance 3 (R3) 0.59 0.52 0.56
    Resistance 2 (R2) 0.52 0.47 0.52 0.55
    Resistance 1 (R1) 0.46 0.44 0.46 0.46 0.54
    Pivot Point 0.39 0.39 0.39 0.39 0.39
    Support 1 (S1) 0.33 0.34 0.34 0.34 0.26
    Support 2 (S2) 0.26 0.31 0.26 0.25
    Support 3 (S3) 0.20 0.26 0.24
    Support 4 (S4) 0.21